DIAGNOS Inc.
DGNOF
Rank in Stocks
#24712
DIAGNOS Inc. is a technology firm that delivers software-based services across... DIAGNOS Inc. is a technology firm that delivers software-based services across a broad international footprint, encompassing Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. A significant portion of its operations focuses on healthcare, where it provides Computer Assisted Retina Analysis (CARA). This advanced web-based platform is designed to support medical professionals in the early detection of diabetic retinopathy. It also empowers eye care specialists by enabling clear visualization of both standard retinal features and any pathological changes. Beyond its healthcare offerings, DIAGNOS Inc. extends its expertise through consulting services, specializing in the fields of data analytics and artificial intelligence (AI). Established in 1998, the company maintains its corporate headquarters in Brossard, Canada.
Share Price
$0.2551
Last synced: 2026-11-09
Market Cap
$31.12M
Change (1 day)
-1.88%
Change (1 year)
21.71%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade DIAGNOS Inc. (DGNOF)
Category
Healthcare
EPS for DIAGNOS Inc. (DGNOF)
EPS as of March 2026 TTM: $-0.03
According to DIAGNOS Inc.'s latest financial reports, its current EPS (TTM) is $-0.03. At the end of 2025 the company had an EPS of $-0.03, equal to its 2024 EPS of $-0.03.
EPS history for DIAGNOS Inc. from 2002 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.03 | -1.67% |
| 2025 | $-0.03 | 6.62% |
| 2024 | $-0.03 | 14.44% |
| 2023 | $-0.03 | 16.39% |
| 2022 | $-0.02 | -44.26% |
| 2021 | $-0.04 | -36.17% |
| 2020 | $-0.07 | -55.34% |
| 2019 | $-0.15 | 13.66% |
| 2018 | $-0.13 | -26.86% |
| 2017 | $-0.18 | -21.96% |
| 2016 | $-0.23 | 0.87% |
| 2015 | $-0.23 | 20.54% |
| 2014 | $-0.19 | -37.68% |
| 2013 | $-0.30 | -13.29% |
| 2012 | $-0.35 | 36.41% |
| 2011 | $-0.26 | -34.60% |
| 2010 | $-0.39 | 7.71% |
| 2009 | $-0.37 | 284.14% |
| 2008 | $-0.10 | -35.41% |
| 2007 | $-0.15 | -4.53% |
| 2006 | $-0.15 | -71.23% |
| 2005 | $-0.54 | 660.20% |
| 2004 | $-0.07 | -85.38% |
| 2003 | $-0.48 | -78.55% |
| 2002 | $-2.25 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $3.86 | -13,184.75% |
US
|
|
| $-1.05 | 3,459.32% |
US
|
|
| $1.79 | -6,175.59% |
AU
|
|
| $1.64 | -5,659.32% |
US
|
|
| $2.08 | -7,150.85% |
US
|
Questions about DIAGNOS Inc.'s earnings per share (EPS)
What is DIAGNOS Inc.'s earnings per share (EPS)?
DIAGNOS Inc.'s earnings per share (EPS) over the last twelve months is $-0.03, as of Mar 2026.
What was DIAGNOS Inc.'s earnings per share (EPS) in 2025?
In 2025, DIAGNOS Inc.'s earnings per share (EPS) was $-0.03, compared with $-0.03 in 2024.
How has DIAGNOS Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, DIAGNOS Inc.'s earnings per share (EPS) was highest in 2022 ($-0.02) and lowest in 2020 ($-0.07).
How does DIAGNOS Inc.'s earnings per share (EPS) compare with similar companies?
DIAGNOS Inc.'s earnings per share (EPS) ($-0.03) is higher than that of 1 of the 5 similar companies listed above. The highest among them is GE HealthCare Technologies Inc., with $3.86.